Omalizumab in the treatment of eosinophilic granulomatosis with polyangiitis (EGPA): single-center experience in 18 cases

BACKGROUND: Data are limited regarding the effectiveness of omalizumab in patients with eosinophilic granulomatosis with polyangiitis (EGPA). Our aim was to evaluate the clinical and functional effectiveness of omalizumab in patients with EGPA in long-term follow-up. METHODS: This study was a retros...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:World Allergy Organ J
Main Authors: Celebi Sozener, Zeynep, Gorgulu, Begum, Mungan, Dilsad, Sin, Betul Ayse, Misirligil, Zeynep, Aydin, Omur, Bavbek, Sevim
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2018
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6276141/
https://ncbi.nlm.nih.gov/pubmed/30524647
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40413-018-0217-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados